Maravai LifeSciences
MRVI
MRVI
158 hedge funds and large institutions have $344M invested in Maravai LifeSciences in 2026 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 51 increasing their positions, 52 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
6.28% less ownership
Funds ownership: 89.23% → 82.95% (-6.3%)
18% less capital invested
Capital invested by funds: $421M → $344M (-$77.2M)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Holders
158
Holding in Top 10
4
Calls
$1.29M
Puts
$1.08M
Top Buyers
| 1 | +$6.4M | |
| 2 | +$2.94M | |
| 3 | +$2.49M | |
| 4 |
First Eagle Investment Management
New York
|
+$2.46M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.89M |
Top Sellers
| 1 | -$18.1M | |
| 2 | -$7.67M | |
| 3 | -$6.86M | |
| 4 |
1WCM
12 West Capital Management
New York
|
-$5.63M |
| 5 |
EP
Eversept Partners
New York
|
-$2.34M |
